Herrmann Evan S, Weerts Elise M, Vandrey Ryan
Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine.
Behavioral Pharmacology Research Unit and Division of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Exp Clin Psychopharmacol. 2015 Dec;23(6):415-21. doi: 10.1037/pha0000053. Epub 2015 Oct 12.
Over 300,000 individuals enter treatment for cannabis-use disorders (CUDs) in the United States annually. Cannabis withdrawal is associated with poor CUD-treatment outcomes, but no prior studies have examined sex differences in withdrawal among treatment-seeking cannabis users. Treatment-seeking cannabis users (45 women and 91 men) completed a Marijuana Withdrawal Checklist (Budney, Novy, & Hughes, 1999, Budney, Moore, Vandrey, & Hughes, 2003) at treatment intake to retrospectively characterize withdrawal symptoms experienced during their most recent quit attempt. Scores from the 14-item Composite Withdrawal Discomfort Scale (WDS), a subset of the Marijuana Withdrawal Checklist that corresponds to valid cannabis withdrawal symptoms described in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; APA, 2013) were calculated. Demographic and substance-use characteristics, overall WDS scores, and scores on individual WDS symptoms were compared between women and men. Women had higher overall WDS scores than men, and women had higher scores than men on 6 individual symptoms in 2 domains, mood symptoms (i.e., irritability, restlessness, increased anger, violent outbursts), and gastrointestinal symptoms (i.e., nausea, stomach pain). Follow-up analyses isolating the incidence and severity of WDS symptoms demonstrated that women generally reported a higher number of individual withdrawal symptoms than men, and that they reported experiencing some symptoms as more severe. This is the first report to demonstrate that women seeking treatment for CUDs may experience more withdrawal then men during quit attempts. Prospective studies of sex differences in cannabis withdrawal are warranted.
在美国,每年有超过30万人因大麻使用障碍(CUDs)接受治疗。大麻戒断与CUD治疗效果不佳有关,但此前尚无研究调查寻求治疗的大麻使用者在戒断方面的性别差异。寻求治疗的大麻使用者(45名女性和91名男性)在治疗开始时完成了一份大麻戒断清单(Budney、Novy和Hughes,1999年;Budney、Moore、Vandrey和Hughes,2003年),以回顾性描述他们最近一次尝试戒烟期间经历的戒断症状。计算了14项综合戒断不适量表(WDS)的得分,该量表是大麻戒断清单的一个子集,与《精神疾病诊断与统计手册》(第5版;美国心理学会,2013年)中描述的有效的大麻戒断症状相对应。比较了女性和男性的人口统计学和物质使用特征、总体WDS得分以及各个WDS症状的得分。女性的总体WDS得分高于男性,并且在情绪症状(即易怒、烦躁不安、愤怒增加、暴力爆发)和胃肠道症状(即恶心、胃痛)这两个领域的6个个体症状上,女性的得分也高于男性。对WDS症状的发生率和严重程度进行的后续分析表明,女性通常报告的个体戒断症状数量比男性多,并且她们报告某些症状更为严重。这是第一份表明寻求CUD治疗的女性在戒烟尝试期间可能比男性经历更多戒断症状的报告。有必要对大麻戒断中的性别差异进行前瞻性研究。